Composition
Vinpocetine - 5 mg; Has helped. lactose, MCC, povidone K-25, magnesium stearate, sodium carboxymethyl starch

Pharmacological action

The mechanism of action of vinpocetine consists of several elements: it improves cerebral blood flow and metabolism, has a beneficial effect on the rheological properties of blood. The neuroprotective effect is realized by reducing the unfavorable cytotoxic effect of excitatory amino acids. Increases the exchange of serotonin and norepinephrine in the brain, stimulates the noradrenergic neurotransmitter system and has an antioxidant effect. Improves microcirculation in the brain by inhibiting platelet aggregation, reducing pathologically increased blood viscosity, increasing erythrocyte deformability and inhibiting adenoein reuptake; promotes the transition of oxygen into cells by reducing the affinity of erythrocytes for it. Selectively increases cerebral blood flow by reducing cerebral vascular resistance without significantly affecting systemic blood circulation parameters (blood pressure (BP), cardiac output, heart rate, total peripheral vascular resistance); does not cause the effect of "stealing".

Indications
Neurology: symptomatic therapy of the consequences of ischemic stroke, vascular vertebrobaelilar insufficiency, vascular dementia, cerebrovascular atherosclerosis, posttraumatic, andpertensive encephalopathy. Ophthalmology: chronic vascular diseases of the retina and choroid of the eye. OTOLOGY: decreased perceptual hearing acuity, Meniere's disease, tinnitus.